These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 22086560

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D, Fior D, Bonaffini PA, Capraro C, Leni D, Corso R, Sironi S.
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S, Horger T, Oelker A, Kloth C, Nikolaou K, Schulze M, Horger M.
    Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of hepatocellular carcinoma with computed tomography perfusion imaging.
    Bayraktutan Ü, Kantarci A, Oğul H, Kizrak Y, Özyiğit Ö, Yüceler Z, Genç B, Özoğul B.
    Turk J Med Sci; 2014 Jun; 44(2):193-6. PubMed ID: 25536723
    [Abstract] [Full Text] [Related]

  • 9. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
    Fischer MA, Kartalis N, Grigoriadis A, Loizou L, Stål P, Leidner B, Aspelin P, Brismar TB.
    Eur Radiol; 2015 Nov; 25(11):3123-32. PubMed ID: 25903707
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease.
    Li JP, Zhao DL, Jiang HJ, Huang YH, Li DQ, Wan Y, Liu XD, Wang JE.
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):43-9. PubMed ID: 21269934
    [Abstract] [Full Text] [Related]

  • 12. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M, Kloth C, Kaufmann S, Nikolaou K, Bösmüller H, Horger M, Thaiss WM.
    Cancer Imaging; 2017 Jun 28; 17(1):18. PubMed ID: 28659180
    [Abstract] [Full Text] [Related]

  • 13. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Perl RM, Portugall J, Hinterleitner C, Hinterleitner M, Kloth C, Walter SS, Bitzer M, Horger MS.
    Anticancer Res; 2021 Mar 28; 41(3):1451-1458. PubMed ID: 33788737
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
    Fischer MA, Marquez HP, Gordic S, Leidner B, Klotz E, Aspelin P, Alkadhi H, Brismar TB.
    Eur Radiol; 2017 Mar 28; 27(3):1074-1080. PubMed ID: 27368924
    [Abstract] [Full Text] [Related]

  • 16. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Mulé S, Pigneur F, Quelever R, Tenenhaus A, Baranes L, Richard P, Tacher V, Herin E, Pasquier H, Ronot M, Rahmouni A, Vilgrain V, Luciani A.
    Eur Radiol; 2018 May 28; 28(5):1977-1985. PubMed ID: 29168007
    [Abstract] [Full Text] [Related]

  • 17. Liver perfusion CT during hepatic arteriography for the hepatocellular carcinoma: dose reduction and quantitative evaluation for normal- and ultralow-dose protocol.
    Watanabe S, Katada Y, Gohkyu M, Nakajima M, Kawabata H, Nozaki M.
    Eur J Radiol; 2012 Dec 28; 81(12):3993-7. PubMed ID: 22980216
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
    Lee DH, Lee JM, Klotz E, Han JK.
    Invest Radiol; 2016 Jul 28; 51(7):430-4. PubMed ID: 26756941
    [Abstract] [Full Text] [Related]

  • 20. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
    Sahani DV, Holalkere NS, Mueller PR, Zhu AX.
    Radiology; 2007 Jun 28; 243(3):736-43. PubMed ID: 17517931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.